1) Chronic pain affects 19% of people and often leads to reduced ability to work or job loss due to inadequate pain management. Ketamine is an NMDA receptor antagonist that has been used as an anesthetic and analgesic drug since the 1960s.
2) A study looked at the efficacy and safety of ketamine treatment for chronic pain in healthy volunteers and patients with Complex Regional Pain Syndrome type 1 (CRPS-1). The study found ketamine reduced experimental and chronic pain in CRPS patients with no changes in vital signs or liver function.
3) The difference in timing between the onset and offset of ketamine's analgesic effects suggests it has a modulatory effect on chronic pain processes beyond just acute pain relief.